circGFRA1 Promotes Ovarian Cancer Progression By Sponging miR-449a

被引:36
作者
Liu, Jie [1 ]
Yu, Furong [1 ]
Wang, Shufen [1 ]
Zhao, Xia [1 ]
Jiang, Feng [1 ]
Xie, Jing [1 ]
Deng, Min [2 ,3 ]
机构
[1] Univ South China, Affiliated Hosp 1, Dept Gynaecol & Obstet, Hengyang, Hunan, Peoples R China
[2] Guangzhou Med Univ, Canc Hosp, Guangzhou, Guangdong, Peoples R China
[3] Guangzhou Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
circular RNAs; circGFRA1; miR-449a; GFRA1; competitive endogenous RNAs; ovarian cancer; PROLIFERATION; PROGNOSIS;
D O I
10.7150/jca.31615
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Backgroud: Increasing studies show that circular RNAs (circRNAs) play important roles in tumor progression. However, the function of circRNAs in ovarian cancer is mostly unclear. Methods: We detected the expression of circGFRA1 by quantitative real-time PCR (qRT-PCR) in 50 pairs of ovarian cancer tissues and adjacent normal tissues. Then, we explored the function of circGFRA1 in ovarian cancer progression, such as cell proliferation, apoptosis and invasion. Moreover, we performed luciferase reporter and RNA immunoprecipitation (RIP) assay to study the competing endogenous RNA (ceRNA) function of circGFRA1 in ovarian cancer progression. Results: qRT-PCR showed that circGFRA1 was overexpressed in ovarian cancer tissues. Inhibition of circGFRA1 suppressed cell proliferation and invasion, but induced cell apoptosis in ovarian cancer. Luciferase reporter and RIP assay revealed that circGFRA1 could regulate the expression of GFRA1 by sponging miR-449a. Conclusions: In summary, circGFRA1 regulated GFRA1 expression and ovarian cancer progression by sponging miR-449a. circGFRA1 could be a potential diagnostic biomarker and therapeutic target for ovarian cancer.
引用
收藏
页码:3908 / 3913
页数:6
相关论文
共 28 条
[1]  
[Anonymous], 2018, CA-CANCER J CLIN, DOI DOI 10.3322/CAAC.21492
[2]  
[Anonymous], 2018, JOULE
[3]  
[Anonymous], J BIOCH
[4]  
[Anonymous], INT J BIOL MACROMOL
[5]   An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast Cancer [J].
Bhakta, Sunil ;
Crocker, Lisa M. ;
Chen, Yvonne ;
Hazen, Meredith ;
Schutten, Melissa M. ;
Li, Dongwei ;
Kuijl, Coenraad ;
Ohri, Rachana ;
Zhong, Fiona ;
Poon, Kirsten A. ;
Go, Mary Ann T. ;
Cheng, Eric ;
Piskol, Robert ;
Firestein, Ron ;
Fourie-O'Donohue, Aimee ;
Kozak, Katherine R. ;
Raab, Helga ;
Hongo, Jo-Anne ;
Sampath, Deepak ;
Dennis, Mark S. ;
Scheller, Richard H. ;
Polakis, Paul ;
Junutula, Jagath R. .
MOLECULAR CANCER THERAPEUTICS, 2018, 17 (03) :638-649
[6]   Hsa_circRNA_103809 regulated the cell proliferation and migration in colorectal cancer via miR-532-3p/FOXO4 axis [J].
Bian, Longjun ;
Zhi, Xiaofei ;
Ma, Lilin ;
Zhang, Jiaxuan ;
Chen, Peisheng ;
Sun, Shiyu ;
Li, Juanjuan ;
Sun, Yi ;
Qin, Jun .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 505 (02) :346-352
[7]  
Cao S, 2018, IMMUNOL CELL BIOL
[8]   MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins [J].
Chen, Hong ;
Lin, Yi-Wei ;
Mao, Ye-Qing ;
Wu, Jian ;
Liu, Yun-Fu ;
Zheng, Xiang-Yi ;
Xie, Li-Ping .
CANCER LETTERS, 2012, 320 (01) :40-47
[9]   The biogenesis and emerging roles of circular RNAs [J].
Chen, Ling-Ling .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2016, 17 (04) :205-211
[10]   MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets [J].
Chen, Shu-peng ;
Liu, Bao-xin ;
Xu, Jie ;
Pei, Xiao-feng ;
Liao, Yi-ji ;
Yuan, Feng ;
Zheng, Fang .
BMC CANCER, 2015, 15